HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serum concentration of macrophage-derived chemokine may be a useful inflammatory marker for assessing severity of atopic dermatitis in infants and young children.

Abstract
Chemokines are responsible for the trafficking of leukocytes to sites of inflammation. Serum chemokine levels were previously shown to be increased in adult patients with atopic dermatitis (AD). We tested whether serum concentrations of chemokines, including macrophage-derived chemokine (MDC), thymus and activation-regulated chemokine (TARC), eotaxin (EOX), interferon gamma inducible protein 10 (IP-10) and monocyte chemotactic protein 1 (MCP-1), are useful inflammatory markers for assessing AD severity in infants and young children. To investigate this, we assessed the severity of AD clinically using the SCORing Atopic Dermatitis (SCORAD) index system. Serum chemokine concentrations were determined by sandwich enzyme immunoassay. Twenty AD patients with a median age of 2.1 years [interquartile range (IQR): 0.6-4.2] were recruited. Their SCORAD score was 23.5 (12.5-33.5). Serum concentrations of MDC, TARC, EOX, IP-10 and MCP-1 were 2551 (1978-3935), 1469 (1125-3070), 68 (57-85), 126 (101-226) and 518 (419-614) pg/ml, respectively. Serum MDC levels correlated with SCORAD (r = 0.608, p = 0.004) and its extent (r = 0.629, p = 0.003) and intensity (r = 0.557, p = 0.011) components. Serum TARC concentration showed weaker correlation with extent (r = 0.474, p = 0.035) and intensity (r = 0.465, p = 0.039) of skin involvement but not SCORAD. The median serum levels of MDC (3131 vs. 2394 pg/ml; p = 0.031) and EOX (80 vs. 61 pg/ml; p = 0.046) were also higher in children with moderate as compared with mild AD. The other chemokines did not correlate with AD severity. In conclusion, our results suggest that serum MDC concentration may be a useful inflammatory marker for assessing AD severity in infants and young children.
AuthorsTing Fan Leung, Kwok Chiu Ma, Kam Lun Hon, Christopher W K Lam, Helene Wan, Chung Yi Li, Iris H S Chan
JournalPediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology (Pediatr Allergy Immunol) Vol. 14 Issue 4 Pg. 296-301 (Aug 2003) ISSN: 0905-6157 [Print] England
PMID12911508 (Publication Type: Comparative Study, Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers
  • CCL11 protein, human
  • CCL17 protein, human
  • CCL22 protein, human
  • Chemokine CCL11
  • Chemokine CCL17
  • Chemokine CCL2
  • Chemokine CCL22
  • Chemokine CXCL10
  • Chemokines, CC
  • Chemokines, CXC
  • Inflammation Mediators
Topics
  • Biomarkers (blood)
  • Chemokine CCL11
  • Chemokine CCL17
  • Chemokine CCL2 (blood)
  • Chemokine CCL22
  • Chemokine CXCL10
  • Chemokines, CC (blood)
  • Chemokines, CXC (blood)
  • Child Welfare
  • Child, Preschool
  • Dermatitis, Atopic (blood)
  • Female
  • Hong Kong
  • Humans
  • Infant
  • Infant Welfare
  • Inflammation Mediators (blood)
  • Male
  • Severity of Illness Index
  • Skin Tests
  • Statistics as Topic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: